๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vaccine development: Recombinant vaccinia for prevention of hepatitis B

โœ Scribed by Beale, John

Book ID
109736438
Publisher
Nature Publishing Group
Year
1984
Tongue
English
Weight
261 KB
Volume
311
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Novel nanoparticles for the delivery of
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
โœ Dhruba J. Bharali; Vandana Pradhan; Galina Elkin; Wu Qi; Alan Hutson; Shaker A. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 354 KB

We describe the use of methoxypolyethylene glycol-poly(lactide-co-glycolide) nanoparticles as a delivery system for recombinant hepatitis B surface antigen (HBsAg). Evaluation of the stability and release kinetics of nanoencapsulated HBsAg in vitro in serum revealed an initial burst effect and a sub

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
โœ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.